Cyclosporine Increases Human Immunodeficiency Virus Type 1 Vector Transduction of Primary Mouse Cells
- 1 August 2006
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 80 (15) , 7769-7774
- https://doi.org/10.1128/jvi.02427-05
Abstract
Murine primary cells are poorly permissive to human immunodeficiency virus type 1 (HIV-1) vector infection. Retroviral infectivity is influenced by dominant inhibitors such as TRIM5alpha. Sensitivity to TRIM5alpha is altered by interactions between cyclophilin A and the HIV-1 capsid. Here we demonstrate that competitive inhibitors of cyclophilins, cyclosporine or the related Debio-025, stimulate HIV-1 vector transduction of primary murine cells, including bone marrow and macrophages, up to 20-fold. Unexpectedly, the infectivity of an HIV-1 mutant or a simian lentivirus that does not recruit cyclophilin A is also stimulated by these drugs. We propose that cyclosporine and related compounds will be useful tools for experimental infection of murine primary cells. It is possible that HIV-1 infection of murine cells is inhibited by dominant factors related to immunophilins.Keywords
This publication has 30 references indexed in Scilit:
- Naturally Occurring Capsid Substitutions Render HIV-1 Cyclophilin A Independent in Human Cells and TRIM-cyclophilin-resistant in Owl Monkey CellsJournal of Biological Chemistry, 2005
- Human Immunodeficiency Virus Type 1 Vectors with Alphavirus Envelope Glycoproteins Produced from Stable Packaging CellsJournal of Virology, 2005
- Murine T Cells Potently Restrict Human Immunodeficiency Virus InfectionJournal of Virology, 2004
- The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeysNature, 2004
- Capsid-Dependent and -Independent Postentry Restriction of Primate Lentivirus Tropism in Rodent CellsJournal of Virology, 2004
- Continuous high-titer HIV-1 vector productionNature Biotechnology, 2003
- Gene transduction efficiency in cells of different species by HIV and EIAV vectorsGene Therapy, 2002
- Postentry Restriction to Human Immunodeficiency Virus-Based Vector Transduction in Human MonocytesJournal of Virology, 2001
- Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cellsGene Therapy, 2000
- Molecular recognition in the HIV-1 capsid/cyclophilin A complex 1 1Edited by J. A. WellsJournal of Molecular Biology, 1997